There’s new uncertainty about updated COVID-19 shots this fall after the Trump administration’s handling of a shot from ...

The Trump administration's effort to impose new requirements on Novavax's COVID-19 vaccine -- the nation's only traditional ...

Novavax stock was climbing again on Monday after the company expressed new confidence in the eventual approval of its ...

Novavax's protein-only vaccine is once again expected to move from emergency approval to full approval status following a pause.

The President Donald Trump administration's request for Novavax Inc. to conduct new clinical trials for its COVID-19 vaccine ...

01. Confusion over the Food and Drug Administration’s delay in granting full approval to Novavax’s Covid-19 vaccine deepened over the weekend when the agency’s commissioner, Marty Makary ...

CHICAGO, April 24 (Reuters) - Thousands of Americans campaigning for the Novavax (NVAX.O), opens new tab COVID-19 booster got some good news this week: the FDA signaled it might still win approval ...

Full approval from the FDA means a product can stay on the market even after a health emergency ends. HealthDay News — Novavax’s COVID-19 vaccine could soon receive full approval from the US ...

Federal regulators are asking Novavax NVAX-4.03%decrease; red down pointing triangle to complete an additional randomized clinical trial on its Covid-19 vaccine after previously delaying approval ...

CHICAGO (Reuters) -Thousands of Americans campaigning for the Novavax COVID-19 booster got some good news this week: the FDA signaled it might still win approval after Health Secretary Robert F.

showcasing the Novavax COVID-19 vaccine's effectiveness and reduced side effects compared to a competitor's vaccine. This positive announcement aligns with a 17.8% increase in the company's share ...